Abbott Laboratories (ABT) P/FCF 25.3 | Overview

Search global stocks & ETFs...Ctrl K

Learn Mode

Abbott LaboratoriesABT

$108.00

$0.73 (0.681%)

at close

$108.23

$0.23 (0.214%)

after hours · 11:46 PM

3.67/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

Updates

ABT

Stock Profile

Market Cap

Industry

EPS (TTM)

P/E (TTM)

Div & Yield

FCF Payout Ratio

P/S (TTM)

P/B

Revenue Growth (TTM)

EPS CAGR (3Y)

Diluted Shares

Ex-Dividend

Next Earnings

Forward P/E

Payout Ratio

P/FCF (TTM)

FCF Yield

Earnings Yield

Revenue CAGR (3Y)

Recommended Metric

Score Card

Explore Scores Tab

3.67

Good

Abbott Laboratories has grown revenue at 8.06% over the past year, which suggests sales are increasing. Also, it has a free cash flow margin of 15.84%, which suggests the company is very profitable.

Valuation Score

Key Score

5.00

Very Good

Management

3.00

Average

Growth

3.00

Average

Profitability

4.00

Good

Fin. Health

2.00

Bad

Dividends

3.00

Average

Analyst

4.00

Good

Financials

Explore Financial Tab ›

Revenue

Earnings

Free Cash Flow

Insider Transactions

Explore Insider Tab ›

Buy Transactions

Sell Transactions

Peers

Select stocks to compare

BSXBoston Scientific Corp

$46.04

-0.04%

GEHCGe Healthcare Technologies Inc

$71.90

+12.15%

IDXXIdexx Laboratories Inc

$569.77

+0.04%

ISRGIntuitive Surgical Inc

$353.10

-2.40%

EWEdwards Lifesciences Corp

$85.76

+2.49%

BDXBecton Dickinson And Co

ZBHZimmer Biomet Holdings, Inc

$97.15

+1.46%

Price Targets & Ratings

View Analysis

1-year price targets, ending Jun 28, 2027

Current

$108.00

Baseline

High

$142.80

▲

32.22%

Avg

$120.04

▲

11.14%

Low

$92.92

▼

-13.96%

Analyst Ratings based on 35 Analysts

Strong Buy

31%

Buy

40%

Hold

29%

Sell

00%

Strong Sell

00%

About

Stock News

View All Updates